shares of BioNTech SE (BNTX) on
BioNTech SE operates as a clinical-stage biotechnology company. The company is headquartered in Mainz, Rheinland-Pfalz and currently employs 1,179 full-time employees. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The company develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.